Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model
- 18 October 2007
- journal article
- Published by Wiley in Acta Ophthalmologica Scandinavica
- Vol. 85 (7) , 777-781
- https://doi.org/10.1111/j.1600-0420.2007.00939.x
Abstract
Intravitreal injections are used extensively to treat retinal diseases. Performing an intravitreal injection increases intraocular volume by the amount of fluid brought into the eye. Whether this influences intraocular pressure (IOP) was investigated here. A biomechanical model relying on 3-dimensional elasticity theory was developed to determine the short-term effect of volume changes on IOP. We calculated the effect for intravitreal injections of 0.1 ml in myopic, emmetropic and hyperopic eyes. Our calculations were compared with IOP measurements obtained immediately after intravitreal injection of 4 mg triamcinolone in 0.1 ml solution (IVTA) in 22 patients. Shortly after the measurement had been taken, IOP was reduced by paracentesis. Immediately after IVTA, measured IOP was elevated by a mean of 40.6 +/- 12.1 mmHg compared with initial pressure (p < 0.001). Measured and calculated IOP were comparable. Eyes with shorter axial length had higher IOP immediately after the injection (p < 0.05). The effect of injected volumes on IOP can be calculated with a biomechanical model. Our results show that paracentesis might be recommended when injecting 0.1 ml of a substance to avoid a short-term increase in IOP. As intravitreal injections are mostly applied in diseases that are due to vascular compromise, it might be prudent not to impair perfusion in those eyes, even for short periods of time.Keywords
This publication has 17 references indexed in Scilit:
- Intravitreal steroids in the management of macular oedemaActa Ophthalmologica Scandinavica, 2006
- Malignant glaucoma as a complication of intravitreal triamcinolone acetonideActa Ophthalmologica Scandinavica, 2006
- Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseasesActa Ophthalmologica Scandinavica, 2005
- Intravitreal use of triamcinolone acetonide: an experimental clinical procedureActa Ophthalmologica Scandinavica, 2005
- Therapie der neovaskulären altersbedingten Makuladegeneration mit Ranibizumab/Lucentis™Klinische Monatsblätter für Augenheilkunde, 2005
- Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiologyActa Ophthalmologica Scandinavica, 2004
- Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularizationOphthalmology, 2003
- INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2000
- Pressure-volume relation for the living human eyeCurrent Eye Research, 2000
- MANOMETRIC STUDIES OF THE PRESSURE VOLUME RELATIONSHIP IN LIVING AND ENUCLEATED EYES OF INDIVIDUAL HUMAN SUBJECTSBritish Journal of Ophthalmology, 1962